Global Genome Engineering Editing Supply, Demand and Key Producers, 2026-2032
Description
The global Genome Engineering Editing market size is expected to reach $ 31660 million by 2032, rising at a market growth of 18.0% CAGR during the forecast period (2026-2032).
Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.
This report studies the global Genome Engineering Editing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genome Engineering Editing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genome Engineering Editing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genome Engineering Editing total market, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Genome Engineering Editing total market, key domestic companies, and share, (USD Million)
Global Genome Engineering Editing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Genome Engineering Editing total market by Type, CAGR, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Genome Engineering Editing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon(Horizon Discovery), Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Genome Engineering Editing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Genome Engineering Editing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Genome Engineering Editing Market, Segmentation by Type:
CRISPR RNP
CRISPR mRNA
CRISPR Virus Delivery
Others
Global Genome Engineering Editing Market, Segmentation by Application:
RUO
GMP
Companies Profiled:
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon(Horizon Discovery)
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
Illumina
Editas Medicine
Agilent Technologies
QIAGEN NV
Key Questions Answered
1. How big is the global Genome Engineering Editing market?
2. What is the demand of the global Genome Engineering Editing market?
3. What is the year over year growth of the global Genome Engineering Editing market?
4. What is the total value of the global Genome Engineering Editing market?
5. Who are the Major Players in the global Genome Engineering Editing market?
6. What are the growth factors driving the market demand?
Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.
This report studies the global Genome Engineering Editing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genome Engineering Editing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genome Engineering Editing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genome Engineering Editing total market, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Genome Engineering Editing total market, key domestic companies, and share, (USD Million)
Global Genome Engineering Editing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Genome Engineering Editing total market by Type, CAGR, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Genome Engineering Editing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon(Horizon Discovery), Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Genome Engineering Editing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Genome Engineering Editing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Genome Engineering Editing Market, Segmentation by Type:
CRISPR RNP
CRISPR mRNA
CRISPR Virus Delivery
Others
Global Genome Engineering Editing Market, Segmentation by Application:
RUO
GMP
Companies Profiled:
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon(Horizon Discovery)
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
Illumina
Editas Medicine
Agilent Technologies
QIAGEN NV
Key Questions Answered
1. How big is the global Genome Engineering Editing market?
2. What is the demand of the global Genome Engineering Editing market?
3. What is the year over year growth of the global Genome Engineering Editing market?
4. What is the total value of the global Genome Engineering Editing market?
5. Who are the Major Players in the global Genome Engineering Editing market?
6. What are the growth factors driving the market demand?
Table of Contents
122 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Genome Engineering Editing Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

